Following the companys recently-announced plans to merge its consumer technology and medtech divisions, Philips has just announced a new wearable medical device thats been clinically proven to control mild and moderate cases of psoriasis a skin condition that affects more than 125 million people worldwide. <\/p>\n
In a nutshell, psoriasis is caused by the overly-rapid division of skin cells on the epidermis. This exceedingly fast division usuallyleads to the formation of scaly patches and plaques, which are oftentimes itchy and painful. To treat these symptoms, most people generally rely onmedicated creams and ointments, but Philips has developed a new approach. <\/p>\n
The companys latest device, called BlueControl uses a wearable array of 40 high-intensity LEDs to shine specific wavelengths of blue light onto the affected areas of a persons body. This helps to slow down the cell division, and in a number of clinical trials was shown to reduce the symptoms of psoriasis vulgaris by an average of 50 percent. <\/p>\n
Its worth noting that Philips isnt the first to explore the prospect of treating psoriasis with light therapy. Medical scientists have long understood the benefits of sunlight for those who suffer from the condition, and special lamps have even been developed to treat patients. That being said, however, BlueConnect is significant for two reasons: 1.) its doesnt use harmful ultraviolet light, and 2.) its designed to be used at home. <\/p>\n
Related:Light-therapy bus shelters set to cheer up Swedes in winter <\/p>\n
The device comes in the form of small, battery-powered light pod that fits into a wearable strap. This strap is fully adjustable and can be placed virtually anywhere on the body, meaning patients can use it in the comfort of their own homes and cut down on visits to the doctors office. <\/p>\n
Philips says BlueConnect will be prescribed by physicians, and available through distributors in the Netherlands, Germany, and the UK starting this month. No word on when itll roll out in the US, but weve reached out to company representatives and well update this post with additional info as soon as we get it. <\/p>\n
<\/p>\n
Read more here: Following the companys recently-announced plans to merge its consumer technology and medtech divisions, Philips has just announced a new wearable medical device thats been clinically proven to control mild and moderate cases of psoriasis a skin condition that affects more than 125 million people worldwide. In a nutshell, psoriasis is caused by the overly-rapid division of skin cells on the epidermis. Continue reading
\nPhilips unveils BlueControl: a device that fights psoriasis with light therapy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"